Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
6,485,239
-
Share change
-
+1,766,077
-
Total reported value
-
$550,140,166
-
Price per share
-
$84.83
-
Number of holders
-
178
-
Value change
-
+$150,317,906
-
Number of buys
-
97
-
Number of sells
-
39
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2025
As of 31 Dec 2025,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
178 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,485,239 shares.
The largest 10 holders included
Fisher Asset Management, LLC, FOUNDATIONS INVESTMENT ADVISORS, LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, ROYAL BANK OF CANADA, LPL Financial LLC, Anfield Capital Management, LLC, BNP PARIBAS FINANCIAL MARKETS, and GOLDMAN SACHS GROUP INC.
This page lists
178
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.